Introduction:
Extraintestinal pathogenic Escherichia coli (ExPEC) are a leading cause of urinary and systemic infections, where antimicrobial resistance complicates successful treatment. Carbapenems are a last-resort antibiotic; however increasing use of carbapenems has led to the emergence of the blaNDM-1 gene conferring carbapenem-resistance. This poses an enormous threat to public health and has resulted in the emergence of extensively multi-drug resistant (MDR) ExPEC lineages such as E. coli ST101. Here we present the most comprehensive genomic analysis of ST101 to date.
Methods:
7 ST101 isolates carrying blaNDM-1 were sequenced using next generation sequencing, where we determined the complete genome of 2 isolates and draft genome of 5 isolates, enabling complete resolution of the plasmid context of blaNDM-1.
Results:
Genomic comparisons with publicly available ST101 draft genomes revealed ST101 strains cluster into 3 clades (A, B and C) based on isolation source, fimH profile and antimicrobial resistance repertoire. Clades can be further differentiated through their mobile genetic element content (MGE). Only Clade C strains are MDR, encoding resistance to at least 9 different antimicrobial classes, including extended spectrum beta-lactams, with blaNDM-1 encoded on both IncA/C and IncFII plasmids. Additionally, we show how a transposition event of blaNDM-1 together with the entire resistance island, resulted in the transfer of carbapenem resistance from one IncFII plasmid to another.
Conclusions:
These high quality, complete ST101 genomes and plasmids will provide an important reference for further analysis of the role of MGEs in this emerging MDR ExPEC lineage.